PHARMACOTHERAPY AND OUTCOMES OF ACUTE ST-ELEVATION MYOCARDIAL INFARCTION – GENDER DIFFERENCES IN REAL CLINICAL PRACTICE
https://doi.org/10.20996/1819-6446-2013-9-6-650-654
Abstract
Aim. To analyze gender differences in pharmacotherapy and outcomes of ST-elevation myocardial infarction (STEMI) in patients of cardiology hospital in real clinical practice. Material and methods. A continuous pharmacoepidemiological analysis was performed on the base of 153 records of patients with STEMI (men 102, women 51), consecutively admitted to the emergency department of cardiology hospital in the period from October 2010 to April 2011.
Results. Women were on average 10.6 years older than men, had significantly higher incidence of severe comorbid conditions and significantly fewer prescribed medications improving STEMI prognosis - thrombolytics (21% vs 50%; p<0.05), statins (20% vs 53%; p<0.05), beta-blockers (84% vs 91%; p<0.05) and dual antiplatelet therapy (21% vs 59%; p<0.05). Hospital mortality was significantly higher in women than this in men, at that mortality differences persisted for 12 months after discharge.
Conclusion. Older age, higher comorbidity rate, and lower treatment compliance with the current clinical recommendations in female STEMI patients in comparison with these in male STEMI patients contribute to higher hospital mortality and 12-month mortality after discharge in women with STEMI.
Results. Women were on average 10.6 years older than men, had significantly higher incidence of severe comorbid conditions and significantly fewer prescribed medications improving STEMI prognosis - thrombolytics (21% vs 50%; p<0.05), statins (20% vs 53%; p<0.05), beta-blockers (84% vs 91%; p<0.05) and dual antiplatelet therapy (21% vs 59%; p<0.05). Hospital mortality was significantly higher in women than this in men, at that mortality differences persisted for 12 months after discharge.
Conclusion. Older age, higher comorbidity rate, and lower treatment compliance with the current clinical recommendations in female STEMI patients in comparison with these in male STEMI patients contribute to higher hospital mortality and 12-month mortality after discharge in women with STEMI.
About the Authors
P. V. Dolotovskaya
Saratov Research Institute of Cardiology, Saratov
Russian Federation
Russian Federation
E. Y. Rudnichenko
Saratov State Medical University named after V.I. Razumovsky, Saratov
Russian Federation
Russian Federation
N. V. Furman
Saratov Research Institute of Cardiology, Saratov
Russian Federation
Russian Federation
O. V. Reshet'ko
Saratov State Medical University named after V.I. Razumovsky, Saratov
Russian Federation
Russian Federation
References
1. Shalnova S.A., Conrady A.O., Karpov Y.A. et al. The analysis of mortality from cardiovascular disease in 12 regions of the Russian Federation involved in the study «Epidemiology of cardiovascular disease in different regions of Russia» Rossijskij Kardiologicheskij Zhurnal 2012;(5):6-10. Russian (Шальнова С.A., Конради А.О., Карпов Ю.А. и др. Анализ смертности от сердечно-сосудистых заболеваний в 12 регионах Российской Федерации, участвующих в исследовании «Эпидемиология сердечно-сосудистых заболеваний в различных регионах России». Российский Кардиологический Журнал 2012;(5):6-10)
2. Ehrlich A.D, Shevchenko I.I., Alekseev D.V., Gratsiansky N.A. on behalf on RECORD Registry participants. Acute coronary syndrome in clinical practice: gender specific of risk levels, treatment and outcomes: RECORD Registry results. Kardiovaskuljarnaja Terapija I Profilaktika 2011;10(8):45-51. Russian (Эрлих А.Д, Шевченко И.И., Алексеев Д.В., Грацианский Н.А. от имени всех участников регистра «РЕКОРД». Острый коронарный синдром в клинической практике: отличия в степени риска, лечении и исходах у мужчин и женщин (по результатам регистра «РЕКОРД»). Кардиоваскулярная Терапия и Профилактика 2011;10(8):45-51).
3. Jneid H, Fonarow GC, Cannon CP, et al. Sex Differences in Medical Care and Early Death After Acute Myocardial Infarction. Circulation 2008;118:2803-10.
4. Shaw LJ, Bugiardini R, Merz CN. Women and Ischemic Heart Disease: Evolving Knowledge J Am Coll Cardiol 2009; 54(17): 1561-75.
5. Maas AH, Appelman YE. Gender differences in coronary heart disease Neth Heart J 2010;18:598-603.
6. Vaccarino V. Ischemic Heart Disease in Women: Many Questions, Few Facts. Circ Cardiovasc Qual Outcomes 2010;3:111-5.
7. Oganov RG, Maslennikova GYa. Gender specifics of cardiovascular pathology. Kardiovaskuljarnaja Terapija I Profilaktika 2012; 11(4):101-4. Russian (Оганов Р.Г., Масленникова Г.Я. Гендерные различия кардиоваскулярной патологии Кардиоваскулярная Терапия и Профилактика, 2012; 11(4): 101-4).
8. Poon S, Goodman SG, Yan RT, et al Bridging the gender gap: Insights from a contemporary analysis of sex-related differences in the treatment and outcomes of patients with acute coronary syndromes Am Heart J 2012;163:66-73.
9. Enriquez JR, Pratap P, Zbilut JP, et al. Women tolerate drug therapy for coronary artery disease as well as men do, but are treated less frequently with aspirin, beta-blockers, or statins. Gend Med 2008; 5(1): 53-61.
10. Daly C, Clemens F, Sendon LJL, et al Gender Differences in the Management and Clinical Outcome of Stable Angina Circulation 2006;113:490-498
11. Gharacholou SM, Alexander KP, Chen AY, et al. Implications and reasons for the lack of use of reperfusion therapy in patients with ST-segment elevation myocardial infarction: findings from the CRU- SADE initiative. Am Heart J 2010;159:757-63.
12. Barbarash OL, Vasilyeva OA, Tavlueva EV, et al. Gender peculiarities of reperfusion therapy in patients with myocardial infarction with elevation ST. Kardiovaskuljarnaja Terapija I Profilaktika 2010; (8):2-16. Russian (Барбараш О.Л., Васильева О.А., Тавлуева Е.В. И др. Гендерные особенности применения реперфузионной терапии у больных инфарктом миокарда с подъемом сегмента ST. Кардиоваскулярная Терапия и Профилактика 2010;(8):2-16)
13. ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiolo- gy (ESC). Eur Heart J 2011;32(23):2999-3054.
14. Tu JV, Khalid L, Donovan LR, Ko DT. Indicators of quality of care for patients with acute myocardial infarction. CMAJ 2008;179(9):909-15.
15. Stramba-Badiale M, Fox KM, Priori SG, et al. Cardiovascular diseases in women: a statement from the policy conference of the European Society of Cardiology. Eur Heart J 2006; 27: 994-1005.
16. Steg PG, Greenlaw N, Tardif JC. Women and men with stable coronary artery disease have similar clinical outcomes: insights from the international prospective CLARIFY registry. Eur Heart J 2012;33(22):2831-40.
17. Fox KA, Goodman SG, Anderson FAJr, et al. From guidelines to clinical practice: the impact of hospital and geographical characteristics on temporal trends in the management of acute coronary syndromes. The Global Registry of Acute Coronary Events (GRACE). Eur Heart J 2003;24(15): 1414-24.
18. Petrov VI, editor. Applied pharmacoepidemiology. Moscow: GEOTAR-Media; 2008. Russian (Петров В.И., редактор. Прикладная фармакоэпидемиология. М.: ГЭОТАР-Медиа; 2008)
19. Gulati M, Shaw LJ, Merz CN. Myocardial Ischemia in Women – Lessons from the NHLBI WISE Study Clin Cardiol 2012; 35(3): 141-8.
20. Mackay MH, Ratner PA, Johnson JL. Gender differences in symptoms of myocardial ischemia Eur Heart J 2011;32:3107-14.
21. Hemingway H, Langenberg C, Damant J, et al. Prevalence of angina in women versus men. A systematic review and meta-analysis of international variations across 31 countries. Circulation 2008; 117:1526-36.
22. Bugiardini R, Yan AT, Yan RT, et al. Factors influencing underutilization of evidence-based therapies in women Eur. Heart J 2011;32:1337-44.
23. Rosenberg A, Wallentin L, Gitt AK, et al. Sex age and clinical presentation of acute coronary syndromes Eur Heart J 2004; 25: 663-70.
24. Milcent C, Dormont B, Durand-Zaleski I, et al. Gender differences in hospital mortality and use of percutaneous coronary intervention in acute myocardial infarction: microsimulation analysis of the 1999 nationwide French hospitals database. Circulation 2007;115: 833-9.
25. Stramba-Badiale M. Women and research on cardiovascular diseases in Europe: a report from the European Heart Health Strategy (EuroHeart) project. Eur Heart J 2010; 31: 1677-85.
26. Maas AH, van der Schouw YT, Regitz-Zagrosek V. Red alert for women’s heart: the urgent need for more research and knowledge on cardiovascular disease in women Eur Heart J 2011; 32: 1362-8.
27. Vaccarino V, Rathore SS, Wenger NK, et al Sex and racial differences in the management of acute myocardial infarction, 1994 through 2002. N Engl J Med 2005; 353: 671- 82.
28. Hvelplund A, Galatius S, Madsen M, et al. Women with acute coronary syndrome are less invasively examined and subsequently less treated than men Eur Heart J 2010; 31: 684-90.
29. Vaccarino V. Angina and Cardiac Care. Are There Gender Differences, and If So, Why? Circulation 2006; 113: 467-9.
30. Dey S, Devlin G, Brieger D. et al. Sex-related differences in the presentation, treatment and outcomes among patients with acute coronary syndromes: the Global Registry of Acute Coronary Events. Heart2009; 95(1): 20-6.
Review
For citations:
Dolotovskaya P.V., Rudnichenko E.Y., Furman N.V., Reshet'ko O.V. PHARMACOTHERAPY AND OUTCOMES OF ACUTE ST-ELEVATION MYOCARDIAL INFARCTION – GENDER DIFFERENCES IN REAL CLINICAL PRACTICE. Rational Pharmacotherapy in Cardiology. 2013;9(6):650-654. (In Russ.) https://doi.org/10.20996/1819-6446-2013-9-6-650-654
Views:
785
.jpg)
Email this article 